(Q76331617)
Statements
Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer (English)
Brodowicz T
Kostler WJ
Möslinger R
Tomek S
Vaclavik I
Herscovici V
Wiltschke C
Steger GG
Wein W
Seifert M
Kubista E
1 December 2000